be defined or be inserted in limitation of study if not available. Manuscript is written quite well but there are a few grammatical errors and the meaning of some phrases is not completely clear. All the abbreviations used in the main text should be explained the first time that they appear in the manuscript. Figures are poor-quality. Lastly, bibliography should be supplemented.
REVIEWER

Mark Tyson
Mayo Clinic, USA REVIEW RETURNED 03-May-2018
GENERAL COMMENTS
Only two minor revisions: 1. The authors should describe the covariates that were used to derive the propensity scores. 2. The authors use the term multivariate, but I believe they mean to use multivariable.
REVIEWER
Cerruto Maria Angela University of Verona, Italy REVIEW RETURNED 07-May-2018
GENERAL COMMENTS
The Authors carried out a retrospective observational study on the incidence of UTI and CKD after ICUD. The topic is very interesting but there are some considerations to do. In the abstract (lines 11-14, page 2) the aim of the study is not clear. Moreover exclusion and inclusion criteria are not well defined (lines 21-27, page 2). Patients characteristics are poor. In the results section in the abstract they should better define the control group (a single TURB-T along 5-year follow-up?). what is the meaning of "body structure change" (line 2, page 3). The paragraph from line 4 to line 12 (page 3) is not clear. Advantage instead of advent age.
In the materials and methods the Authors used the National Health Insurance Research DAtabase (NHIRD) in order to obtain information on the occurrence of UTI, septicemia and CKD. Actually the information obtained is on the costs and not on the incidence of these diseases. Therefore, there is a lack of several epidemiological data important in order to better develop the study arriving to correct conclusions. All information derived from a coding. There are no data on preoperative TNM and comorbidities derived from reimbursement coding as well. In materials and methods, mentioning figure 2a of Kaplan Meier curve (line 24, page 6) is not appropriate (they should be described only in the results). Results description is poor as well as discussion. I believe that topic is very interesting but Authors should focus the attention on cost comparing data not only with a control population (that should better described) but also with other type of common UD. The topic of this study is interesting and the aim of the study is well described in the introduction so as well are material and methods. However, the comparison between a group who has been subjected to radical cystectomy and a group subjected to TURBT represents a questionable choice. As has already been proved, radical cystectomy is related to several long-term complications, including UTI especially for ileal conduit diversion. Actually, there are conflicting results in literature: for example, a recent work published on WJU (Clifford TG et al. Urinary tract infections following radical cystectomy and urinary diversion: a review of 1133 patients. World J Urol. 2018 Jan 25. doi:10.1007/s00345-018-2181-2) claims that UTI is a common complication after radical cystectomy (RC) but the type of urinary diversion is not independently associated with a higher risk of infection. In any case radical cystectomy seems to be followed, short-term as well as long-term, to a high percentage of infectious complications.
REVIEWER
The result related to the comparison between the groups cited above almost seems to be obvious.
The same applies to renal function since it has been proved that in the majority of the patients subjected to radical cystectomy a progressive decrease of renal function occurs, probably due to post-operative hydronephrosis, pyelonephritis and ureteroenteric stricture ( Exclusion criteria should include urethral recurrence (if urethrectomy was not performed during radical cystectomy) and possible pelvic radiotherapy performed before/after radical cystectomy for any cause. In TURBT group, eventual administration of intravescical instillation should be specified (and excluded). Moreover in this group the involvement of ureteral orifice should be described and excluded because the resection of the orifice could cause hydronephrosis or vescical ureteral reflux.
Chronic intake of immunosuppressive or nephrotoxic agents should be defined or be inserted in limitation of study if not available.
Manuscript is written quite well but there are a few grammatical errors and the meaning of some phrases is not completely clear. All the abbreviations used in the main text should be explained the first time that they appear in the manuscript. Figures are poor-quality. Lastly, bibliography should be supplemented.
Answer:
Thanks for your comment, according to your suggestion, we reviewed the two articles in WJU and JU with great interest and these two articles mainly focus on the post radical cystectomy complication without bladder preservation control group. In real world, we still not fully understand how much the risk of UTI/CKD increased in patients underwent cystectomy compared with those preserved their bladder.
Therefore, we design a database study with bladder preservation control. Though UTI is a common complication after cystectomy with urinary diversion, the result provides urologist information about the UTI/CKD risk(the risk came from possible hydronephrosis, stricture, shortening of upper urinary tract to conduit…etc) and this might be helpful when providing clinical consultation about bladder preservation treatment strategy or establishment of UTI/CKD prevention protocol after radical cystectomy procedure.
The criteria of this study for ICUD/TURBT group is those patients who survived for at least 5 years and without disease recurrence(in the fig-1 flow chart) which also includes urethral recurrence. We know that the indication for cystectomy and TURBT only is different. It might cause some selection bias to compare patients underwent cystectomy with those underwent TURBT only. Therefore, the exclusion of disease recurrence is to overcome the cancer and disease recurrence related effect (Patients with delayed cystectomy and early recurrence are not considered in this study design because we want to only analyze the health effect after urinary structural change and exclude the complicated cancer staging effect). All these patient is cancer free (cured status with only urinary structural difference) and we design this study to include these two groups of patients to help us identify the relative risk of UTI/CKD after cystectomy and ileal conduit urinary diversion.
In this national database study, it is difficult to obtained the detailed data of immunosuppressive or nephrotoxic agents use. In addition, the effect of intravesical agent after bladder preservation is often short term and we still observe the long term(after 90 days) UTI/CKD risk increasing in ICUD group. We carefully exclude the cisplatin chemotherapy because that is the most common nephrototoxic agent during bladder cancer treatment. We have further described these limitation in our manuscript according to your suggestion.
We have consulted the native speaker for correction of this manuscript. 1. The authors should describe the covariates that were used to derive the propensity scores. Answer: Thanks for your comment. The covariates include age, gender, preoperative comorbidities(stroke, CKD, DM, HTN…etc). These covariates have been described in our revised manuscript.
2. The authors use the term multivariate, but I believe they mean to use multivariable. Answer: We have corrected the error on revised manuscript. The Authors carried out a retrospective observational study on the incidence of UTI and CKD after ICUD. The topic is very interesting but there are some considerations to do. In the abstract (lines 11-14, page 2) the aim of the study is not clear.
Ans: We have rewrited our abstract and a more clear aim was described in the revised version.
Moreover exclusion and inclusion criteria are not well defined (lines 21-27, page 2).
Ans: We have corrected this part of description.
Patients characteristics are poor. In the results section in the abstract they should better define the control group (a single TURB-T along 5-year follow-up?). what is the meaning of "body structure change" (line 2, page 3). The paragraph from line 4 to line 12 (page 3) is not clear. Advantage instead of advent age.
Ans: The control group is defined as last TURBT followed by cancer free status with long enough follow up duration. This definition is described in the revised version. We have change to term "body structural change" to "urinary tract structural change" and correct spelling error about advantage.
In the materials and methods the Authors used the National Health Insurance Research DAtabase (NHIRD) in order to obtain information on the occurrence of UTI, septicemia and CKD. Actually the information obtained is on the costs and not on the incidence of these diseases. Therefore, there is a lack of several epidemiological data important in order to better develop the study arriving to correct conclusions.
All information derived from a coding. There are no data on preoperative TNM and comorbidities derived from reimbursement coding as well.
Ans: The Taiwan NHIRD national database does have its limitation. The limitation of lacking TNM is a limitation of our NHIRD database because that it is not a cancer registry database. Therefore, we excluded UC recurrence and want to only discuss the health effect of urinary tract structural change with cancer free longer than 5 years. All the effort is to exclude cancer related effect and decrease the interference of baseline staging. However, the advantage is its high coverage rate of >99% of the population still make investigator to get the new onset of disease by coding system easily. We use discharge code instead of code from outpatient service to reduce the coding error as possible. This limitation is described in our manuscript. We have tried our best to use multivariate analysis to identify the potential impact of preoperative CKD in our observed endpoint, and use propensity score matching to reduce selection bias. Besides, the aim of this study only included cancer free patients without chemotherapy exposure and with pure ileal conduit urinary diversion. Though many patients were excluded, these strict exclusion criteria is to avoid unnecessary bias from other urinary diversion method, potential situation susceptible to UTI and renal function deterioration. We have disclosed the limitation in manuscript and readers can obtain objective information about limitation from the manuscript.
In materials and methods, mentioning figure 2a of Kaplan Meier curve (line 24, page 6) is not appropriate (they should be described only in the results). Results description is poor as well as discussion.
Ans: We have made correction and add more description in the result section.
I believe that topic is very interesting but Authors should focus the attention on cost comparing data not only with a control population (that should better described) but also with other type of common UD.
Ans: Thanks for your comment. We very agree with your opinion and the case number of other type of UD is really difficult to accumulate if we set 5-year cancer free criteria(in order to overcome the TNM lacking property of this Taiwan NHIRD database). The analysis between ICUD and bladder preservation is a large topic to us including 7 tables. The effect of other type of UD may need further work in the future.
Reviewer: 4
Reviewer Name: Hanan Goldberg Institution and Country: Princess Margaret Cancer Center, Canada
Competing Interests: None declared This is a retrospective population based study comparing UTI and CKD in patients who underwent ileal conduit diversion after radical cystectomy with those who have undergone only TURBT surgery.
The paper is written well, however the main idea of comparing TURBT patients and Ileal conduit patients is not clear to me. These are completely different treatments offered to patients at different stages of the disease. What is the logic in comparing these totally different patient populations? a more interesting question would be to compare on a population based level these outcomes in patients who have had different urinary diversions.
Answer: Thanks for your comment, our study aim is only to analyze the long term effect after urinary structural change of cystectomy with ileal conduit urinary diversion compared with those patients still preserve their bladder. We very agree with your opinion and the case number of other type of UD is really difficult to accumulate if we set 5-year cancer free criteria(in order to overcome the TNM lacking property of this Taiwan NHIRD database). The analysis between ICUD and bladder preservation is a large topic to us including 7 tables. The effect of other type of UD may need further work in the future.
The criteria of this study for ICUD group is those patients who survived for at least 5 years and without disease recurrence. Such inclusion criteria are to obtain data from those patients with cured status and we can focus on the effect of urinary structure change without cancer related effect (cured status with only urinary structural difference). It is important to exclude the impact of cancer related outcome(such as cachexia, poor intake..etc) and therapy(chemotherapy) effect. Both may interfere with the interpretation of our endpoint such as UTI and CKD. In this study, we described the risk of UTI/CKD following surgical intervention with urinary tract structural change of ICUD with enough bladder preservation control. Though it should be more interesting to compare between different UD, the question and aim of this study is still on the risk increase of ICUD(the most common UD after cystectomy). We think this result showed information when providing clinical consultation about bladder preservation treatment strategy or establishment of UTI/CKD prevention protocol for patient underwent ICUD.
The reason the we only include TURBT patients instead of all patient without cystectomy as bladder preserving control is that bladder cancer patients may expose to specific carcinogen which also interferes with renal function and urothelial susceptibility to UTI.
Additional comments and questions:
1. Why did the follow-up period end in 2011? why not continue up to 2017-2018? Ans: The database is released every 5 years. We get these data on 2015 and the latest surgical procedure observed end at 2011. All these patient were followed until December 31, 2015. We have make a clear description in revised manuscript.
6. No data is given on when the UTI and CKD had occurred after surgery? this is extremely important and has significant implications. Was this 30 day postoperatively? 90 day? more? this needs to be addressed and incorporated in the model, and maybe even do some sensitivity analyses for different time dependent outcomes.
Ans: Thanks for your comment and we add two tables (table6 and 7) to analyze the acute and late complication in our study patients. We found that ICUD does increase the UTI/CKD risk whether in acute or late period.
7. In table 3 of the multivariable analysis -Charlson comorbidity score is included together with several comorbidities such as cardiovascular disease, stroke and diabetes. All these are included within the Charlson comorbidity score and therefore are included twice in the model. There certainly is an issue with multicollinearity here that needs to be addressed.
Ans: Thanks for your comment and we delete the CCI in our analysis.
8. There is a lot of important data missing, which the authors partially address in their limitations. This included lack of BMI, bladder cancer risk factors, proper pathological staging? surgical complications? data regarding rural vs. non rural hospitals? academic vs. non academic hospitals? low volume vs. high volume hospitals? It would be essential to acquire and present as much data as possible in this study.
9. No data is given regarding preoperative antibiotics. Did all patients receive them? which kind? Was ERAS protocol performed for all cystectomy patients? how long was hospitalization time for all patients? What percentage of patients were in the ICU after the surgery? were some cystectomy patients give neoadjuvant chemotherapy (I understand that adjuvant chemotherapy patients were excluded), but were neoadjuvant chemotherapy patients excluded as well? all these factors have a tremendous effect on UTI and CKD development.
Answer for 8.9:
Thanks for your comments. We agree that the limitation of database research is really difficult to take many possible confounding factors as you mentioned(BMI, staging, complication, perioperative hospital protocol…etc) into consideration. We disclose these limitations in our revised manuscript. In Taiwan, cystectomy is performed in tertiary medical center and those patients with survival longer than 5 year as inclusion criteria indicated that the quality of cystectomy. We will fully address these factors into manuscript for readers as our limitation. However, according to recent articles describing about the post cystectomy complication(Clifford TG et al. Urinary tract infections following radical cystectomy and urinary diversion: a review of 1133 patients. World J Urol. 2018 Jan 25. doi:10.1007/s00345-018-2181-2 and Eisenberg MS et al. Long-term renal function outcomes after radical cystectomy. J Urol. 2014 Mar;191(3):619-25. doi:10.1016/j.juro.2013.09.011), the detailed data are also missing and may be well-designed prospective study is need based on current reports. For perioperative protocol concern, we have added UTI/UTI with sepsis/CKD within 90 days and after 90 days to discuss about the possible perioperative complication effect). The neoadjuvant is also excluded because the effect of potential nephrotoxicity.
VERSION 2 -REVIEW
REVIEWER
Alessandro Antonelli Spedali Civili di Brescia, Italy REVIEW RETURNED 22-Jul-2018
GENERAL COMMENTS
The authors have revised their article according to suggestions made by editors and reviewers.
REVIEWER
Hanan Goldberg
Princess Margaret Cancer Center, Canada REVIEW RETURNED 13-Jul-2018
GENERAL COMMENTS
In general, my comments have been addressed in the revision.
